TRIM25 targets p300 for degradation

被引:0
|
作者
Elabd, Seham [1 ,2 ]
Pauletto, Eleonora [1 ]
Solozobova, Valeria [1 ]
Eickhoff, Nils [3 ]
Padrao, Nuno [3 ]
Zwart, Wilbert [3 ]
Blattner, Christine [1 ]
机构
[1] Inst Biol & Chem Syst Biol Informat Proc, Karlsruhe, Germany
[2] Alexandria Univ, Med Res Inst, Human Physiol Dept, Alexandria, Egypt
[3] Netherlands Canc Inst, Oncode Inst, Div Oncogen, Amsterdam, Netherlands
关键词
UBIQUITIN-INDEPENDENT DEGRADATION; PROTEINS; BINDING; AGGRESOMES; DYNEIN; ASSOCIATION; PROTEOLYSIS; INHIBITORS; TRANSPORT; RECEPTOR;
D O I
10.26508/lsa.202301980
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
p300 is an important transcriptional co-factor. By stimulating the transfer of acetyl residues onto histones and several key transcription factors, p300 enhances transcriptional initiation and impacts cellular processes including cell proliferation and cell division. Despite its importance for cellular homeostasis, its regulation is poorly understood. We show that TRIM25, a member of the TRIM protein family, targets p300 for proteasomal degradation. However, despite TRIM25's RING domain and E3 activity, degradation of p300 by TRIM25 is independent of TRIM25mediated p300 ubiquitination. Instead, TRIM25 promotes the interaction of p300 with dynein, which ensures a microtubuledependent transport of p300 to cellular proteasomes. Through mediating p300 degradation, TRIM25 affects p300-dependent gene expression.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer
    Wang, Shan
    Kollipara, Rahul K.
    Humphries, Caroline G.
    Ma, Shi-Hong
    Hutchinson, Ryan
    Li, Rui
    Siddiqui, Javed
    Tomlins, Scott A.
    Raj, Ganesh V.
    Kittler, Ralf
    [J]. ONCOTARGET, 2016, 7 (40) : 64921 - 64931
  • [2] Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes
    Yang, Emily
    Huang, Serina
    Jami-Alahmadi, Yasaman
    McInerney, Gerald M.
    Wohlschlegel, James A.
    Li, Melody M. H.
    [J]. PLOS PATHOGENS, 2022, 18 (09)
  • [3] All Paths Lead to TRIM25
    Zhou, Hengbo
    Costello, James C.
    [J]. TRENDS IN CANCER, 2017, 3 (10): : 673 - 675
  • [4] TRiM25 in the Regulation of the Antiviral innate immunity
    Martin-Vicente, Maria
    Medrano, Luz M.
    Resino, Salvador
    Garcia-Sastre, Adolfo
    Martinez, Isidoro
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [5] TRIM25: A central factor in breast cancer
    Tecalco-Cruz, Angeles C.
    Abraham-Juarez, Maria Jazmin
    Solleiro-Villavicencio, Helena
    Ramirez-Jarquin, Josue Orlando
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (08): : 646 - 655
  • [6] Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25
    Yun, Hyeseon
    Jeong, Hong-Rae
    Kim, Do Yeon
    You, Ji-Eun
    Lee, Ji-U
    Kang, Dong-Hee
    Koh, Dong-In
    Ryu, Yea Seong
    Bae, SeungGeon
    Jin, Dong-Hoon
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [7] Degradation of AZGP1 suppresses the progression of breast cancer cells via TRIM25
    Qin, Hai
    Yuan, Yaqin
    Yuan, Manqin
    Wang, Haiyan
    Yang, Yonghong
    [J]. ENVIRONMENTAL TOXICOLOGY, 2024, 39 (02) : 882 - 889
  • [8] Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis
    Yuanliang Yan
    Shangjun Zhou
    Xi Chen
    Qiaoli Yi
    Songshan Feng
    Zijin Zhao
    Yuanhong Liu
    Qiuju Liang
    Zhijie Xu
    Zhi Li
    Lunquan Sun
    [J]. Signal Transduction and Targeted Therapy, 9
  • [9] TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L
    Wong, Derek
    Sogerer, Lisa
    Lee, Samantha S.
    Wong, Victor
    Lum, Amy
    Levine, Adrian B.
    Marra, Marco A.
    Yip, Stephen
    [J]. BMC BIOLOGY, 2020, 18 (01)
  • [10] Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis
    Yan, Yuanliang
    Zhou, Shangjun
    Chen, Xi
    Yi, Qiaoli
    Feng, Songshan
    Zhao, Zijin
    Liu, Yuanhong
    Liang, Qiuju
    Xu, Zhijie
    Li, Zhi
    Sun, Lunquan
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)